Literature DB >> 24513354

Aspirin use and early age-related macular degeneration: a meta-analysis.

Shyalle K Kahawita1, Robert J Casson2.   

Abstract

OBJECTIVE: The aim of this review was to evaluate the evidence for an association between Aspirin use and early age-related macular degeneration (ARMD).
METHODS: A literature search was performed in 5 databases with no restrictions on language or date of publication. Four studies involving 10292 individuals examining the association between aspirin and ARMD met the inclusion criteria. Meta-analysis was carried out by Cochrane Collaboration Review Manager 5.2 software (Cochrane Collaboration, Copenhagen, Denmark).
RESULTS: The pooled odd ratios showed that Aspirin use was associated with early ARMD (pooled odds ratio 1.43, 95% CI 1.09-1.88).
CONCLUSIONS: There is a small but statistically significant association between Aspirin use and early ARMD, which may warrant further investigation. Crown
Copyright © 2014. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24513354     DOI: 10.1016/j.jcjo.2013.07.016

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  5 in total

1.  The Association of Aspirin Use with Age-Related Macular Degeneration Progression in the Age-Related Eye Disease Studies: Age-Related Eye Disease Study 2 Report No. 20.

Authors:  Tiarnan D Keenan; Henry E Wiley; Elvira Agrón; Mary E Aronow; William G Christen; Traci E Clemons; Emily Y Chew
Journal:  Ophthalmology       Date:  2019-06-26       Impact factor: 12.079

2.  Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study.

Authors:  Liubov Robman; Robyn Guymer; Robyn Woods; Stephanie Ward; Rory Wolfe; James Phung; Lauren Hodgson; Galina Makeyeva; Khin Zaw Aung; Tom Gilbert; Jessica Lockery; Y-Anh Le-Pham; Suzanne Orchard; Elsdon Storey; Walter Abhayaratna; Daniel Reid; Michael E Ernst; Mark Nelson; Christopher Reid; John McNeil
Journal:  Contemp Clin Trials Commun       Date:  2017-03-27

3.  Association Between Aspirin Usage and Age-Related Macular Degeneration: An Updated Systematic Review and Meta-analysis.

Authors:  Ruijia Yan; Jing Zhao; Xinai Zhang; Wei Wang; Zhengyao Jiang
Journal:  Front Pharmacol       Date:  2022-03-25       Impact factor: 5.810

4.  Baseline characteristics and age-related macular degeneration in participants of the "ASPirin in Reducing Events in the Elderly" (ASPREE)-AMD trial.

Authors:  Liubov D Robman; Le Thi Phuong Thao; Robyn H Guymer; Rory Wolfe; Robyn L Woods; Lauren Ab Hodgson; James Phung; Galina A Makeyeva; Y-Anh Le-Pham; Suzanne G Orchard; Jewhara Suleiman; Emily Maguire; Ruth E Trevaks; Stephanie A Ward; Moeen Riaz; Paul Lacaze; Elsdon Storey; Walter P Abhayaratna; Mark R Nelson; Michael E Ernst; Christopher M Reid; John J McNeil
Journal:  Contemp Clin Trials Commun       Date:  2020-10-11

5.  Non-steroidal Anti-inflammatory Drug Use and Risk of Age-Related Macular Degeneration in the California Teachers Study.

Authors:  Xiaoqing Xu; Beate Ritz; Anne L Coleman; Zeyan Liew; Dennis Deapen; Eunjung Lee; Leslie Bernstein; Rich Pinder; Sarah F Marshall; Julia E Heck
Journal:  Drugs Aging       Date:  2021-07-26       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.